- Report
- November 2025
- 295 Pages
Global
From €5258EUR$5,850USD£4,629GBP
- Report
- September 2025
- 250 Pages
Global
From €4036EUR$4,490USD£3,553GBP
- Report
- June 2025
- 138 Pages
Global
From €2291EUR$2,549USD£2,017GBP
€2695EUR$2,999USD£2,373GBP
- Report
- August 2025
- 122 Pages
North America
From €2291EUR$2,549USD£2,017GBP
€2695EUR$2,999USD£2,373GBP
- Report
- August 2025
- 195 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1438EUR$1,600USD£1,266GBP
€1798EUR$2,000USD£1,583GBP
- Report
- July 2025
- 350 Pages
Global
From €4448EUR$4,949USD£3,916GBP
- Report
- August 2025
- 150 Pages
Global
From €3018EUR$3,358USD£2,657GBP
€3550EUR$3,950USD£3,126GBP
- Report
- February 2025
- 274 Pages
Global
From €4449EUR$4,950USD£3,917GBP
- Report
- November 2024
- 120 Pages
Global
From €5348EUR$5,950USD£4,708GBP
- Report
- October 2025
- 199 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- October 2025
- 187 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- October 2025
- 184 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- October 2025
- 192 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- October 2025
- 187 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- August 2025
- 183 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- August 2025
- 185 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- August 2025
- 190 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- August 2025
- 193 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP
- Report
- August 2025
- 196 Pages
Global
From €3186EUR$3,545USD£2,805GBP
€3540EUR$3,939USD£3,117GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more